home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

CorMedix Inc. - Common Stock (NQ:CRMD)

7.305 +0.065 (+0.90%)

Streaming Delayed Price Updated: 1:43 PM EDT, Apr 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CorMedix Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

March 25, 2025

The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

CorMedix Stock Loses Almost A Third Of Its Market Cap After Downbeat H1 Revenue Outlook – But Retail Shrugs It Off ↗

March 25, 2025

The company reported earnings of $0.22 per share compared with a loss of $0.26 per share in the corresponding period of 2023, owing to the launch of its lead product, DefenCath.

Via Stocktwits

Nasdaq Gains 50 Points; US New Home Sales Rise In February ↗

March 25, 2025

Via Benzinga

Which stocks are moving before the opening bell on Tuesday? ↗

March 25, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Earnings Preview For Cormedix ↗

October 29, 2024

Via Benzinga

CRMD Stock Earnings: Cormedix Beats EPS for Q1 2024 ↗

May 09, 2024

CRMD stock results show that Cormedix beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Earnings Scheduled For March 25, 2025 ↗

March 25, 2025

Via Benzinga

CorMedix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

March 24, 2025

Via Benzinga

Li Auto, Xponential Fitness And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

March 14, 2025

Via Benzinga

Healthcare Stocks Doing Well But SMID Biotech Looking A Little Frazzled ↗

March 10, 2025

Small caps took another step down this past week as geopolitical events dampened sentiment.

Via Talk Markets

Topics ETFs Stocks / Equities

Cormedix Earnings Preview ↗

March 11, 2024

Via Benzinga

3 Value Stocks That Are Backed By The World’s Largest Activist Hedge Fund ↗

February 25, 2025

Sometimes, hedge funds make risky decisions. But these stocks are at the lower end of the exposure risk spectrum.

Via Talk Markets

Topics Stocks / Equities

Top movers in Friday's after hours session ↗

February 21, 2025

As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Elliott Investment Management Buys Wolfspeed Stock, Bets Against Nvidia In Q4 ↗

February 19, 2025

Elliott Investment Management made several portfolio moves in the fourth quarter, closing multiple options positions and shaking up the activist firm's technology exposure.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 07, 2025

Via Benzinga

Two Big Weeks To Play A Rally In Biotech And Healthcare Stocks ↗

January 06, 2025

The healthcare sector is lagging over the past year and recent quarter with the XLV flat for 2024 and down over 4% for the recent quarter.

Via Talk Markets

Topics ETFs Stocks / Equities

Smaller Cap Biotechs Are In Season: How Are We Doing? ↗

November 07, 2024

SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range.

Via Talk Markets

CorMedix (CRMD) Q3 2024 Earnings Call Transcript ↗

October 30, 2024

CRMD earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 30, 2024

Via Benzinga

Biotech Momentum Trades For The Q4 Rally ↗

October 29, 2024

The biotech sector made an interim peak in late February followed by an active summer in very choppy trading.

Via Talk Markets

Biotech Stocks : Are You A Trader Or A Longer Term Investor? ↗

October 01, 2024

Biotech bull market is intact as indicated by large cap biopharma and the best performing funds.

Via Talk Markets

Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday ↗

August 26, 2024

Via Benzinga

CorMedix (CRMD) Q2 2024 Earnings Call Transcript ↗

August 14, 2024

CRMD earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

CRMD Stock Earnings: Cormedix Meets EPS, Misses Revenue for Q2 2024 ↗

August 14, 2024

CRMD stock results show that Cormedix met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

Trading SMID Biotech Stocks In A Volatile Market ↗

July 01, 2024

Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a...

Via Talk Markets

CorMedix (CRMD) Q1 2024 Earnings Call Transcript ↗

May 09, 2024

CRMD earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

Biotech on a Budget: 7 Stocks Under $10 With Huge Potential ↗

April 15, 2024

With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 12, 2024

Via Benzinga

CorMedix (CRMD) Q4 2023 Earnings Call Transcript ↗

March 12, 2024

CRMD earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Earnings Scheduled For March 12, 2024 ↗

March 12, 2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com